Seqera, founded in 2018, develops software for life sciences organisations that need to manage complex computational workflows at scale. Its core product, the Seqera Platform, centralises data, orchestrates analysis pipelines, and brings research infrastructure under a single, secure and compliant environment. The platform can be deployed on-premises or across any cloud, and is used by over 150 organisations including pharmaceutical companies, genomics labs, research hospitals, and government institutions.
The company's technical work spans genomics data analysis, drug discovery pipelines, workflow orchestration, and scalable collaborative data analysis. Seqera also maintains several open-source bioinformatics tools that underpin the platform: Nextflow, a widely used workflow orchestration framework; MultiQC, for aggregating quality control reports; Wave, for container provisioning; and Fusion, a distributed virtual filesystem designed for cloud-based pipelines.
Seqera's software is built to address fragmentation in research infrastructure - disconnected data sources, brittle pipelines, and ageing systems that slow the path from discovery to development. The platform is designed to let researchers and engineers concentrate on scientific work rather than infrastructure management, with security and compliance built into the architecture from the outset.